Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

E.U.-wide marketing approval granted for Muse

Dec. 14, 1998

SomatoKine provides significant benefit in severe burn trial

Dec. 14, 1998

GH secretagogue and SERM show additive effects in ovariectomized rats

Dec. 11, 1998

Phase I clinical trials of female sexual dysfunction Rx commence

Dec. 11, 1998

J&J to terminate collaboration with Ergo Science for Ergoset development

Dec. 9, 1998

Hemosol completes patient recruitment in phase II trial with Hemolink

Dec. 9, 1998

Cerus presents preclinical data on RBC pathogen inactivation system and begins clinical trials

Dec. 9, 1998

Celtrix reports positive clinical results for SomatoKine; company seeks development partners

Dec. 8, 1998

NexMed reports progress with development of ED therapeutic in China

Dec. 8, 1998

Safer and more effective SERM compounds reported in development at Signal

Dec. 7, 1998

Popular Stories

Today's news in brief
BioWorld
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
ADPD 2026: Can we prevent dementia? Scientists quantify it
BioWorld
Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 17, 2026